Gene therapy for the nervous system.
Ho
D Y
DY
Department of Biological Sciences, Stanford University, USA.
Sapolsky
R M
RM
D000818:Animals; D016923:Cell Death; D002561:Cerebrovascular Disorders / Q000628:therapy; D004298:Dopamine / Q000096:biosynthesis; D015316:Genetic Therapy; D005822:Genetic Vectors; D018698:Glutamic Acid / Q000378:metabolism; D006801:Humans; D009422:Nervous System Diseases / Q000473:pathology / Q000503:physiopathology / Q000628:therapy*; D009474:Neurons / Q000502:physiology; D018377:Neurotransmitter Agents / Q000096:biosynthesis / Q000378:metabolism; D010300:Parkinson Disease / Q000628:therapy; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000235:genetics; D014780:Viruses / Q000235:genetics
D018377:Neurotransmitter Agents; D019253:Proto-Oncogene Proteins c-bcl-2; D018698:Glutamic Acid; D004298:Dopamine